Literature DB >> 26879857

Application of PEG-400 as a green biodegradable polymeric medium for the catalyst-free synthesis of spiro-dihydropyridines and their use as acetyl and butyrylcholinesterase inhibitors.

Ammar Maryamabadi1, Alireza Hasaninejad2, Najmeh Nowrouzi1, Gholamhossein Mohebbi3, Behvar Asghari4.   

Abstract

A simple, efficient and green approach for the synthesis of spiro-dihydropyridines derivatives by one-pot multi-component reaction of isatin or acenaphthoquinone derivatives (1 equiv) with malononitrile (1 equiv) and N,N'-substituted-2-nitroethene-1,1-diamines (1 equiv) in PEG-400 under catalyst-free conditions is described. This method provides several advantages such as environmental friendliness, short reaction time, and simple workup procedure for the synthesis of biologically important compounds. The ability of synthesized compounds in inhibition of acetyl and butyrylcholinesterase were investigated both in vitro and in silico. All compounds showed moderate to high level activity against both acetyl and butyrylcholinesterase. There was a good correlation between in vitro and in silico studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase inhibition; Butyrylcholinesterase inhibition; Catalyst-free; Multi-component reactions; Spiro-dihydropyridines

Mesh:

Substances:

Year:  2016        PMID: 26879857     DOI: 10.1016/j.bmc.2016.02.019

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  One-pot, sequential four-component synthesis of novel heterocyclic [3.3.3] propellane derivatives at room temperature.

Authors:  Maryam Beyrati; Alireza Hasaninejad
Journal:  RSC Adv       Date:  2018-04-17       Impact factor: 4.036

2.  Eco-friendly polyethylene glycol (PEG-400): a green reaction medium for one-pot, four-component synthesis of novel asymmetrical bis-spirooxindole derivatives at room temperature.

Authors:  Alireza Hasaninejad; Maryam Beyrati
Journal:  RSC Adv       Date:  2018-01-09       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.